ClinicalTrials.Veeva

Menu
H

Hemato Oncology Clinic | Ahmedabad, India

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

LY3537982
Anastrozole
Exemestane
Imlunestrant
Tamoxifen
FOLFIRI
Tyrosine
Repotrectinib
Pembrolizumab
Letrozole

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

6 of 7 total trials

A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

This is a trial to evaluate the efficacy, safety, and tolerability of adagrasib plus pembrolizumab plus platinum-doublet chemotherapy versus placebo...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Placebo
Drug: Pemetrexed

The purpose of this study is to assess if adding LY3537982 (olomorasib) in combination with standard of care anti-cancer drugs is more effective than...

Enrolling
Carcinoma, Non-Small-Cell Lung
Neoplasm Metastasis
Drug: Carboplatin
Drug: Pemetrexed

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cance...

Active, not recruiting
Breast Neoplasms
Drug: Anastrozole
Drug: Tamoxifen

The purpose of this study is to evaluate the efficacy and safety of repotrectinib and crizotinib in participants with locally advanced or metastatic...

Active, not recruiting
Carcinoma, Non-Small-Cell Lung
Drug: Crizotinib
Drug: Repotrectinib

The purpose of the study is to compare the efficacy and safety of Luspatercept vs epoetin alfa in the treatment of anemia in adults due to IPSS-R ver...

Enrolling
Myelodysplastic Syndromes
Biological: Epoetin Alfa
Biological: Luspatercept

The main purpose of this study is to assess if olomorasib in combination with pembrolizumab is more effective than the pembrolizumab and placebo comb...

Enrolling
Carcinoma, Non-Small-Cell Lung
Drug: Olomorasib
Drug: Placebo

Trial sponsors

Lilly logo
Bristol-Myers Squibb (BMS) logo
Merck KGaA (EMD Serono) logo
Mirati Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems